Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2021-07-19 00:00:00 ET · period of report 2021-07-19 · accession 0001209191-21-047304 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-19 | 2021-07-19 | ADPT | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | S - Sale+OE | $36.12 | -651 | 9,158 | -7% | -$23.5K |
| D | 2021-07-19 | 2021-07-19 | ADPT | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | M - OptEx | $22.55 | +651 | 9,809 | +7% | +$14.7K |
| D | 2021-07-19 | 2021-07-19 | ADPT | Palaniappan Jyoti | SVP, Diagnostics, T-Detect | M - OptEx | $0.00 | -651 | 104.4K | -0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-19 | S | D | 651 | $36.12 | 9,158 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-19 | M | A | 651 | $22.55 | 9,809 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-07-19 | M | D | 651 | $0.00 | 104,393 | D | $22.55 · — to 2030-03-19 | 651 Common Stock | (F2) The options vested with respect to 1/4 of such shares on March 18, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |